Monopar Therapeutics Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 9.3M |
| FY2018 | 9.3M |
| FY2019 | 10.6M |
| FY2020 | 11.5M |
| FY2021 | 12.5M |
| FY2022 | 12.7M |
| FY2023 | 2.8M |
| FY2024 | 3.8M |
| FY2025 | 7.4M |
| FY2026 | 6.7M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 9.3M |
| FY2018 | 9.3M |
| FY2019 | 10.6M |
| FY2020 | 11.5M |
| FY2021 | 12.5M |
| FY2022 | 12.7M |
| FY2023 | 2.8M |
| FY2024 | 3.8M |
| FY2025 | 7.4M |
| FY2026 | 6.7M |